2019
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
Ciprofloxacin
|
|
Azithromycin
|
|
Pretomanid
|
|
Trimethoprim
|
Detailed explanation-1: -The guidelines include a new recommendation on the use of a novel all-oral 6-month regimen composed of bedaquiline, pretomanid, linezolid and moxifloxacin (BPaLM) in people suffering from MDR/RR-TB or MDR/RR-TB with additional resistance to fluoroquinolones (pre-XDR-TB).
Detailed explanation-2: -Second-line injectable antituberculosis drugs (aminoglycosides and capreomycin) are the main drugs used in the management of resistant tuberculosis. Their preserved efficacy in the case of multi-drug-resistant bacillus is counterbalanced by frequent adverse events.
Detailed explanation-3: -Developed by a non-profit organization, TB Alliance, Pretomanid is the newest anti-TB drug, prescribed as part of the BPaL regimen, which includes two other drugs – Bedaquiline and Linezolid.